Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

vTv Therapeutics (VTVT) Non Operating Income: 2014-2025

Historic Non Operating Income for vTv Therapeutics (VTVT) over the last 7 years, with Sep 2025 value amounting to -$34,000.

  • vTv Therapeutics' Non Operating Income fell 140.00% to -$34,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $325,000, marking a year-over-year increase of 319.59%. This contributed to the annual value of $160,000 for FY2024, which is 110.69% up from last year.
  • vTv Therapeutics' Non Operating Income amounted to -$34,000 in Q3 2025, which was down 162.96% from $54,000 recorded in Q2 2025.
  • vTv Therapeutics' Non Operating Income's 5-year high stood at $1.8 million during Q1 2023, with a 5-year trough of -$3.6 million in Q3 2023.
  • For the 3-year period, vTv Therapeutics' Non Operating Income averaged around -$121,545, with its median value being $54,000 (2025).
  • Per our database at Business Quant, vTv Therapeutics' Non Operating Income slumped by 1,003.23% in 2023 and then spiked by 1,858.82% in 2024.
  • vTv Therapeutics' Non Operating Income (Quarterly) stood at $634,000 in 2021, then crashed by 197.48% to -$618,000 in 2022, then soared by 102.75% to $17,000 in 2023, then surged by 1,858.82% to $333,000 in 2024, then plummeted by 140.00% to -$34,000 in 2025.
  • Its Non Operating Income was -$34,000 in Q3 2025, compared to $54,000 in Q2 2025 and -$28,000 in Q1 2025.